Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:15 AM
Ignite Modification Date:
2025-12-25 @ 4:15 AM
NCT ID:
NCT00642720
Eligibility Criteria:
Inclusion Criteria:
* Active acromegaly.
* Serum total IGF-I levels must have been normalized during long-term treatment with long-acting somatostatin analogs
* Age between 18 and 80
Exclusion Criteria:
* Any contra-indication for the use of long-acting somatostatin analogs, as e.g. the use of anti-coagulants.
* Subjects with pituitary tumors that compress the optic chiasm
* Patients with insulin dependent diabetes
* Patients with cancer
* Patients with kidney- or liver function disturbances
* Fertile female patients that refuse to take contraceptives during the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT00642720
Study Brief:
Protocol Section:
NCT00642720